Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1

Cancer Research

Volumn 56, Issue 13, 1996, Pages 2979-2984

  Shimada, Tsutomu ^a,c   Hayes, Carrie L ^b   Yamazaki, Hiroshi ^c   Amin, Shantu ^d   Hecht, Stephen S ^d   Guengerich, F Peter ^a,b   Sutter, Thomas R ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITROPYRENE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ACRYLONITRILE; AFLATOXIN; ANTHRACENE DERIVATIVE; AROMATIC AMINE; AROMATIC HYDROCARBON; AZO DYE; BENZO[A]PYRENE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CARCINOGEN; CHRYSENE DERIVATIVE; CYTOCHROME P450; DIMETHYLBENZ[A]ANTHRACENE; DIMETHYLNITROSAMINE; DNA; FLUORANTHENE; HETEROCYCLIC AMINE; MESSENGER RNA; MYCOTOXIN; PHENANTHRENE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; QUINOLINE DERIVATIVE; STERIGMATOCYSTIN;

ADULT; ARTICLE; CATALYSIS; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MICROSOME; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; TUMOR;

ADULT; AMINES; ANIMALS; BIOTRANSFORMATION; CARCINOGENS; CATALYSIS; CHRYSENES; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; HUMANS; ISOENZYMES; MICROSOMES; MUTAGENS; NADPH-FERRIHEMOPROTEIN REDUCTASE; POLYCYCLIC COMPOUNDS; PRODRUGS; RABBITS; RNA; SACCHAROMYCES CEREVISIAE; SUBSTRATE SPECIFICITY;

EID: 0030008731     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Gonzalez, F. J. Human cytochromes P450: problems and prospects. Trends Pharmacol. Sci., 13: 346-352, 1992.
2. Guengerich, F. P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res., 48: 2946-2954, 1988.
3. Guengerich, F P., and Shimada, T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res Toxicol , 4 391-407, 1991.
4. Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res., 49: 3218-3228, 1989.
5. Shimada, T , Gillam, E. M. J., Sandhu, P., Guo, Z., Tukey, R. H., and Guengcrich, F. P. Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli Simplified bacterial systems for genotoxicity assays. Carcinogenesis (Lond.), 15. 2523-2529, 1994
6. NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl. Acad. Sci. USA, 86: 462-465, 1989.
7. Shimada, T., Yun, C-H., Yamazaki, H , Gautier, J-C , Beaune, P H , and Guengerich, F. P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol., 41: 856-864, 1992.
8. Shimada, T , and Guengerich, F. P Activation of amino-α-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and a copper phthatocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes Cancer Res., 51: 5284-5291, 1991.
9. Shimada, T., Martin, M. V , Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F P Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo[a]pyrene, 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res , 49: 6304-6312, 1989.
10. Shimada, T , Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270. 414-423, 1994.
11. Savas, Ü., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R. Mouse cytochrome P450EF, representative of a new 1B subfamily of cytochrome P450s Cloning, sequence determination, and tissue expression J. Biol. Chem., 269: 14905-14911, 1994.
12. Shen, Z , Liu, J., Wells, R. L , and Elkind, M. M. cDNA cloning, sequence analysis, and induction by aryl hydrocarbons of a murine cytochrome P450 gene, Cyp1b1. DNA Cell Biol., 13. 763-769, 1994.
13. Bhattacharyya, K. K , Brake, P. B., Eltom, S. E., Otto, S. A., and Jefcoate, C. R. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1: demonstration of a unique tissue-specific pattern of hormonal and aryl hydrocarbon receptor-linked regulation. J. Biol. Chem., 270: 11595-11602, 1995.
14. Walker, N , Gastel, J. A., Costa, L. T., Clark, G. C., Lucier, G W , and Sutter, T. R Rat CYP1B1 an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis, 16: 1319-1327, 1995.
15. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y. P., Jabs, E. W., Li, X , Yin, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 209: 13092-13099, 1994.
16. Pottenger, L. K., and Jefcoate, C. R. Characterization of a novel cytochrome P450 from the transformable cell line. C3H/10T1/2 Carcinogenesis (Lond.), 11: 321-327, 1990.
17. Otto, S , Bhattacharyya, K. K , and Jefcoate, C. R. Polycyclic aromatic hydrocarbon metabolism in rat adrenal, ovary, and testis microsomes is catalyzed by the same novel cytochrome P450 (P450RAP). Endocrinology, 131: 3067-3076, 1995.
18. Christou, M., Savas, U., Spink, D C., Gierthy, J. F., and Jefcoate, C R. Co-expression of human CYP1A1 and a human analog of cytochrome P-450-EF in response to 2,3,7,8-tetrachloro-dibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis (Lond ), 15: 725-732, 1994.
19. Harvey, R. G. Synthesis of the dihydrodiol and diol epoxide metabolites of carcinogenic polycyclic hydrocarbons In: R. G. Harvey (ed.), Polycyclic Hydrocarbons and Carcinogenesis, pp. 35-62. American Chemical Society Symposium Series No. 283. Washington, DC: American Chemical Society, 1995
20. Pataki, J., Lee, H , and Harvey, R. G. Carcinogenic metabolites of 5-methylchrysene Carcinogenesis (Lond.), 4: 399-402, 1983.
21. Amin, S., Huie, K., Hecht, S. S., and Harvey, R. G. Synthesis of 6-methylchrysene-1,2-diol-3,4-epoxides and comparison of their mutagenicity to 5-methylchrysene-1,2-diol-3,4-epoxides. Carcinogenesis (Lond.), 7: 2067-2070, 1986.
22. Misra, B., Amin, S., and Hecht, S. S. Dimethylchrysene diol epoxides: mutagenicity in Salmonella typhimurium, tumorigenicity in newborn mice, and reactivity with deoxyadenosine in DNA. Chem Res. Toxicol , 5: 248-254, 1992.
23. Krzeminski, J , Lin, J. M , Amin, S., and Hecht, S. S. Synthesis of fjord region diol epoxides as potential ultimate carcinogens of dibenzo[a,l]pyrene. Chem. Res. ToxicoL. 7: 125-129, 1994.
24. Misra, B., and Amin, S An improved synthesis of anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide via 4-methoxybenzo[c]phenanthrene. J Org. Chem., 55: 4478-4480, 1990.
25. Balanikas, G , Hussain, N., Amin, S , and Hecht, S. S. Oxidation of polynuclear aromatic hydrocarbons with ceric ammonium sulfate: preparation of quinones and lactones. J. Org. Chem , 53: 1007-1010, 1988.
26. He, Z-M., Rice, J. E., and LaVote, E. Synthesis of anti- and syn-diol epoxides of trans-4,5-dihydro-4,5-dihydroxybenzo[j]fluoranthrene J Org. Chem., 57: 1784-1789, 1992.
27. Geddie, J. E , Amin, S , Huie, K., and Hecht, S S Formation and tumorigenicity of benzo[b]fluoranthrene metabolites in mouse epidermis Carcinogenesis (Lond ), 8: 1579-1584, 1987.
28. Sutter, T. R., Guzman, K , Dold, K. M , and Greenlee, W F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1b Science (Washington DC), 254. 415-418, 1991.
29. Guo, Z , Gillam, E. M. J., Ohmori, S., Tukey, R. H , and Guengerich, F P. Expression of modified human cytochrome P450 1A1 in Escherichia coli: effects of 5′ substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch Biochem Biophys , 312. 436-446, 1994
30. Sandhu, P , Guo, Z., Baba, T , Martin, M. V., Tukey, R H , and Guengerich, F. P. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch Biochem. Biophys., 309: 168-177, 1994.
31. Gillam, E. M. J., Baba, T , Kim, B-R., Ohmori, S , and Guengerich, F. P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme Arch. Biochem Biophys., 305: 123-131, 1993.
32. Yasukochi, Y , and Masters, B S. S. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography J Biol. Chem., 251 5337-5344, 1976.
33. Shimada, T , Misono, K. S., and Guengerich, F P Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem., 261: 909-921, 1986.
34. Shimada, T., and Nakamura, S Cytochrome P-450-mediated activation of procarcinogens and promutagens to DNA-damaging products by measuring expression of umu gene in Salmonella typhimurium TA1535/pSK1002. Biochem. Pharmacol., 36: 1979-1987, 1987.
35. Shimada, T., Oda, Y., Yamazaki, H. Mimura, M., and Guengerich, F. P. SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009. In: K. W. Adolph (ed.), Methods in Molecular Genetics, Vol. 5. Gene and Chromosome Analysis, pp. 342-355. Orlando, FL: Academic Press, 1994
36. Miller, J. H. Experiments in Molecular Genetics, p. 352. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1972.
37. Omura, T , and Sato, R. The carbon monoxide-binding pigment of liver microsomes I. Evidence for its hemoprotein nature J. Biol. Chem., 239: 2370-2378, 1964.
38. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent J Biol. Chem., 243: 1331-1332, 1951.
39. 1-450: complementary DNA and aminoacid sequence. Science (Washington DC), 228: 80-83, 1985.
40. Quattrochi, L. C., Okino, S T., Pendurthi, U. R., and Tukey, R. H. Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6. DNA (NY), 4: 395-400, 1985
41. Parri, G., Jardine, K., and McBurney, M. W. Multiple CArG boxes in the human cardiac actin gene promoter required for expression in embryonic cardiac muscle cells developing in vitro from embryonal carcinoma cells. Mol. Cell. Biol., 11. 4796-4803, 1991.
42. Cleveland, D. W , Lopata, M. A., MacDonald, R. J., Cowan, N. J., Rutter, W. J., and Kirschner, M. W. Number and evolutionary conservation of α-and γ-actin genes using specific cloned cDNA products. Cell, 20. 95-105, 1980.
43. Renaud, J. P., Peyronneau, M. A., Urban, P., Truan, G., Cullin, C., Pompon, D., Beaune, P., and Mansuy, D. Recombinant yeast in drug metabolism. Toxicology, 82: 39-52, 1993.
44. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl Acad Sci. USA, 86: 7696-7700, 1989.
45. Rifkind, A. B., Tseng, L., Hirsch, M B., and Lauersen, N. H. Aryl hydrocarbon hydroxylase activity and microsomal cytochrome content of human fetal tissues. Cancer Res., 38: 1572-1577, 1978.
46. Pelkonen, O. Differential inhibition of aryl hydrocarbon hydroxylase in human foetal liver, adrenal gland and placenta. Acta Pharmacol Toxicol., 41: 306-316, 1977
47. Raucy, J. L., and Carpenter, S L The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J. Pharmacol. Toxicol. Methods. 29: 121-128, 1993.
48. Kato, T , Nakasa, H , Ohmori, S., Kamataki, T., Itahashi, K., Shimada, T., Rikihisa, T., and Kitada, M Possible occurrence of P450 related to P450 HFLb in extrahepatic tissues of human fetuses and its contribution to metabolic activation of promutagens. Mutat Res , 310: 73-77, 1994.
49. Wood, A W., Chang, R. L., Levin, W., Ryan, D E , Thomas, P E , Mah, H. D., Karle, J. M., Yagi, H , Jerina, D. M., and Conney, A. H. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides. Cancer Res., 39: 4069-4077, 1979.
50. Gozukara, E. M , Belvedere, G., Robinson, R. C., Deutsch, J., Coon, M. J., Guengerich, F. P , and Gelboin, H. V. The effect of epoxide hydratase on benzo-[a]pyrene diol epoxide hydrolysis and binding to DNA and mixed-function oxidase proteins. Mol. Pharmacol., 19: 153-161, 1981.
51. Hecht, S. S., Amin, S., Huie, K., Melikian, A. A., and Harvey, R. G. Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectivity from methylchrysenes in mouse epidermis. Cancer Res., 47. 5310-5315, 1987.
52. Hecht, S. S., Amin, S., Lin, J. M., Rivenson, A., Kurtzke, C., and El-Bayoumy, K. Mammary carcinogeniciry in female CD rats of a diol epoxide metabolite of fluoranthene, a commonly occurring environmental pollutant. Carcinogenesis (Lond.), 16: 1433-1435, 1995
53. Amin, S., Krzeminski, J., Rivenson, A., Kurtzke, C., Hecht, S. S., and El-Bayoumy, K. Mammary carciogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene, and dibenzo[a,l]pyrene. Carcinogenesis (Lond.), 16: 1971-1974, 1995.
54. Amin, S , Desai, D., Dai, W., Harvey, R G., and Hecht, S. S. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo-[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cryclopenta[def]-chrysene, and fluoranthene. Carcinogenesis (Lond.), 16: 2813-2817, 1995.
55. Levin, W., Chang, R. L., Wood, A. W., Thakker, D. R., Yagi, H., Jerina, D. M., and Conney, A. H. Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo[c]phenanthrene in murine tumor models. Cancer Res., 46: 2257-2261, 1986.
56. Koehl, W., Amin, S , Hecht, S S., Yamazaki, H , Tateishi, T., and Guengerich, F P. Metabolic activation of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Proc Am. Assoc. Cancer Res., 36 154, 1995.
57. Melikian, A A., Amin, S., Huie, K , Hecht, S. S , and Harvey, R. G. Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers. Cancer Res., 48: 1781-1787, 1988.
58. El-Bayoumy, K., Amin, S., and Hecht, S S. Effects of 6-nitrosubstitution on 5-methylchrysene tumorigenicity, mutagenicity and metabolism. Carcinogenesis (Lond.), 7: 673-676, 1986.
59. Melikian, A A., Prahalad, K A., Amin, S , and Hecht, S. S. Comparative DNA binding of polynuclear aromatic hydrocarbons and their dihydrodiol and bay region diolepoxides. Carcinogenesis (Lond.), 12: 1665-1670, 1991.
60. Savas, Ü., Christou, M. and Jefcoate, C. R. Mouse endometrium stromal cells express a polycyclic aromatic hydrocarbon-inducible cytochrome P450 that closely resembles the novel P450 in mouse embryo fibroblasts (P450EF). Carcinogenesis (Lond.), 14: 2013-2018, 1993
61. Hecht, S. S., El-Bayoumy, K., Rivenson, A., and Amin, S. Potent mammary carcinogenicity in female CD rats of a fjord region diol epoxide of benzo[c]phenanthrene compared to a bay region diol epoxide of benzo[a]pyrene. Cancer Res , 54: 21-24, 1994.
62. Day, B. W., Sahali, Y., Hutchins, D. A., Wildschútte, M , Pastorelli, R., Nguyen, T. T., Naylor, S., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R. Fluoranthene metabolism: human and rat liver microsomes display different stereoselective formation of the trans-2,3-dihydrodiol Chem. Res Toxicol , 5. 779-786, 1992